Asthalin Inhaler is indicated in adults, adolescents and children aged 4 to 11 years.
For babies and children under 4 years of age, see Dosage & Administration and Pharmacology: Pharmacodynamics under Actions.
Asthalin Inhaler provides short-acting (4 to 6 hour) bronchodilation with fast onset (within 5 minutes) in reversible airways obstruction.
It is particularly suitable for the relief and prevention of asthma symptoms. It should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognised by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).
Asthalin Inhaler may also be used in the treatment of the reversible component of airways obstruction.